Phenylketonuria Market

Phenylketonuria Market studies the Phenylketonuria (PKU) market. Phenylketonuria (PKU) is an inborn error of metabolism that results in decreased metabolism of the amino acid phenylalanine. Untreated PKU can lead to intellectual disability, seizures, behavioral problems, and mental disorder. It may also result in a musty smell and lighter skin. Babies born to mothers who have poorly treated PKU may have heart problems, a small head, and low birth weight.

Phenylketonuria Market mainly focuses on the treatment for PKU.

Phenylketonuria Market contains market size and forecasts of Phenylketonuria (PKU) in global, including the following market information:

Global Phenylketonuria (PKU) Market Revenue, 2017-2022, 2023-2028, ($ millions)

Global Phenylketonuria (PKU) Market Sales, 2017-2022, 2023-2028, (K Units)

Global top five Phenylketonuria (PKU) companies in 2021 (%)

The global Phenylketonuria (PKU) market was valued at 1372.6 million in 2021 and is projected to reach US$ 2634.5 million by 2028, at a CAGR of 9.8% during the forecast period.

The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.

Medications Segment to Reach $ Million by 2028, with a % CAGR in next six years.

The global key manufacturers of Phenylketonuria (PKU) include Biomarin, Mead Johnson, Abbott, Nutricia, Dr. Sch?r, Vitaflo, Cambrooke, PKU Perspectives and Firstplay Dietary. etc. In 2021, the global top five players have a share approximately % in terms of revenue.

We surveyed the Phenylketonuria (PKU) manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.

Total Market by Segment:

Global Phenylketonuria (PKU) Market, by Type, 2017-2022, 2023-2028 ($ Millions) & (K Units)

Global Phenylketonuria (PKU) Market Segment Percentages, by Type, 2021 (%)

Medications

Supplements

Others

Global Phenylketonuria (PKU) Market, by Application, 2017-2022, 2023-2028 ($ Millions) & (K Units)

Global Phenylketonuria (PKU) Market Segment Percentages, by Application, 2021 (%)

Household

Hospital

Global Phenylketonuria (PKU) Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions) & (K Units)

Global Phenylketonuria (PKU) Market Segment Percentages, By Region and Country, 2021 (%)

North America

US

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Nordic Countries

Benelux

Rest of Europe

Asia

China

Japan

South Korea

Southeast Asia

India

Rest of Asia

South America

Brazil

Argentina

Rest of South America

Middle East & Africa

Turkey

Israel

Saudi Arabia

UAE

Rest of Middle East & Africa

Competitor Analysis

The report also provides analysis of leading market participants including:

Key companies Phenylketonuria (PKU) revenues in global market, 2017-2022 (Estimated), ($ millions)

Key companies Phenylketonuria (PKU) revenues share in global market, 2021 (%)

Key companies Phenylketonuria (PKU) sales in global market, 2017-2022 (Estimated), (K Units)

Key companies Phenylketonuria (PKU) sales share in global market, 2021 (%)

Further, the report presents profiles of competitors in the market, key players include:

Biomarin

Mead Johnson

Abbott

Nutricia

Dr. Sch?r

Vitaflo

Cambrooke

PKU Perspectives

Firstplay Dietary